Back to AVBP
D. E. Shaw & Co., Inc. AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
6
Latest value
$787K
Q3 2026
Peak value
$30.3M
First seen
Q3 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2024 | $206K |
| Q4 2025 | $4.7M |
| Q1 2026 | $8.5M |
| Q2 2026 | $30.3M |
| Q3 2026 | $26.7M |
| Q3 2026 | $787K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $787K | 26.0K | — | — |
| Q3 2026 | $26.7M | 882.5K | — | — |
| Q2 2026 | $30.3M | 872.0K | — | — |
| Q1 2026 | $8.5M | 368.8K | — | — |
| Q4 2025 | $4.7M | 233.3K | — | — |
| Q3 2024 | $206K | 8.8K | — | — |
Other funds holding AVBP
$156.9M
$149.1M
$136.5M
$119M
$105.2M
$101.5M